ARCHIVES

Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

DeVita Changes Mind On OSP Phase Out Reasons, But Presses for “Internalizing” Coordinating Portfolio

January 1, 1988

The NLST at a Glance

August 2, 2013

Jackson Lab Should Be Rebuilt With Federal Funds, Panel Says

September 29, 1989

NCI Trials Listed

June 25, 2010

FDA Approves Lymphoseek For Imaging Lymph Nodes

March 29, 2013

Give Young Women Data, Not Guidelines, Advisors Tell NCI; consensus For Over 50

October 29, 1993